Navigation Links
New angel capital centered on GenTel agreement with big pharma

Madison, Wis. - GenTel BioSciences, a privately-held biotechnology company, has completed what it calls a critical round of financing activity by raising an additional $500,000 to pursue a new partnership with a large pharmaceutical company.

Alex Vodenlich, president and CEO of GenTel, said the identity of the pharma company would not be anno......

Full article >>> gov/Act255">Act 255, the state's investment tax credit program, and Wisconsin Investment Partners, a Madison-based angel investment network that emphasizes life-science investments.

"They [GenTel] have had good marketplace acceptance and nice sales growth, albeit for a young company," said Dick Leazer, a princi......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 02/20/07


Related biology technology :

1. Investor warns of angel-venture funding gap
2. Breaking down Wisconsins angel capital numbers
3. Research explains why women lack equal access to angel capital
4. Capital-raising term sheets for angels and venture capitalists
5. National angel investment grew 11 percent in `06
6. BioSystem Development secures angel funding
7. New Silicon Pastures director envisions more home cooking for Wisconsin angels
8. Milwaukee angel network invests in St. Louis company
9. Small Tree receives additional angel funding
10. Burke would like to double Act 255 angel tax credits
11. Midwest plays small role in VC investment, angel groups to the rescue
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... Hong Kong (PRWEB) , ... May 22, 2017 ... ... the third year in a row in the Aragon Research Globe™ for Corporate ... that align with industry direction and market demand, and effectively perform against those ...
(Date:5/23/2017)... (PRWEB) , ... May 23, 2017 , ... ... Works as Vice President of Clinical Operations. She brings years of expertise ... Yaupon Therapeutics. From her professional foundation as a licensed occupational therapist, through a ...
(Date:5/22/2017)... (PRWEB) , ... May 22, 2017 , ... Stratevi, a ... expanded to the East Coast. It has opened an office in downtown Boston at ... are finding it increasingly more important to generate evidence on the value they provide, ...
(Date:5/21/2017)... ... May 20, 2017 , ... ... the lengthy trial and error process by finding the right antidepressant faster. ... strengthen the doctor-patient relationship through a personalized approach to treatment. , ...
Breaking Biology Technology:
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... 11, 2017 Crossmatch®, a globally-recognized leader ... today announced that it has been awarded a ... Activity (IARPA) to develop next-generation Presentation Attack Detection ... "Innovation has been a driving force within Crossmatch ... allow us to innovate and develop new technologies ...
(Date:4/11/2017)... NXT-ID, Inc. (NASDAQ:   NXTD ) ("NXT-ID" or ... independent Directors Mr. Robin D. Richards and Mr. ... the company,s corporate governance and expertise. ... Gino Pereira , Chief Executive Officer said," ... and benefiting from their considerable expertise as we move forward ...
Breaking Biology News(10 mins):